Difficulty: Medium
Average Score: 67%
Practice
In the management of patients with AIDS, the sulfonamides are often used in combination with inhibitors of folate reductase. However, such combinations have minimal activity against
Correct answer
D
Rationale
In the management of patients with AIDS, the use of sulfonamides in combination with inhibitors of folate reductase is common for treating opportunistic infections. In this context, the correct answer is D) Treponema pallidum. Treponema pallidum is the causative agent of syphilis, a sexually transmitted infection. Sulfonamides in combination with folate reductase inhibitors are not effective against Treponema pallidum due to the specific mechanisms of action of these drugs and the unique characteristics of the bacterium.
Now, let's discuss why the other options are incorrect:
A) Escherichia coli: Sulfonamides are commonly used to treat Escherichica coli infections. Inhibitors of folate reductase can also target this bacterium, so this option is not the correct answer.
B) Nocardia species: Nocardia is a genus of bacteria that can cause various infections, including pulmonary infections. Sulfonamides are actually a first-line treatment for Nocardia infections, so this option is also incorrect.
C) Pneumocystis carinii: Pneumocystis jirovecii (formerly known as Pneumocystis carinii) is a fungus commonly seen in immunocompromised individuals, especially those with AIDS. Sulfonamides, particularly trimethoprim-sulfamethoxazole, are the mainstay of treatment for Pneumocystis jirovecii infections. Therefore, this option is not the correct answer.
Educational context: This question highlights the importance of understanding the mechanisms of action of different antimicrobial agents and how they interact with specific pathogens. It also emphasizes the need for healthcare providers to be aware of the most effective treatment options for various infectious agents, especially in immunocompromised patients like those with AIDS. Understanding these principles is crucial for providing optimal patient care and achieving positive health outcomes.
Now, let's discuss why the other options are incorrect:
A) Escherichia coli: Sulfonamides are commonly used to treat Escherichica coli infections. Inhibitors of folate reductase can also target this bacterium, so this option is not the correct answer.
B) Nocardia species: Nocardia is a genus of bacteria that can cause various infections, including pulmonary infections. Sulfonamides are actually a first-line treatment for Nocardia infections, so this option is also incorrect.
C) Pneumocystis carinii: Pneumocystis jirovecii (formerly known as Pneumocystis carinii) is a fungus commonly seen in immunocompromised individuals, especially those with AIDS. Sulfonamides, particularly trimethoprim-sulfamethoxazole, are the mainstay of treatment for Pneumocystis jirovecii infections. Therefore, this option is not the correct answer.
Educational context: This question highlights the importance of understanding the mechanisms of action of different antimicrobial agents and how they interact with specific pathogens. It also emphasizes the need for healthcare providers to be aware of the most effective treatment options for various infectious agents, especially in immunocompromised patients like those with AIDS. Understanding these principles is crucial for providing optimal patient care and achieving positive health outcomes.